2201973 Preview

NSF/ANSI 455-4-2020

Good Manufacturing Practices for Over-the-Counter Drugs

standard by NSF/ANSI , 11/01/2020

This document has been replaced. View the most recent version.

View all product details

Historical

Track It

Language:
    • Available Formats
    • Options
    • Availability
    • Priced From ( in USD )
    • Secure PDF 🔒
    • 👥
    • Immediate download
    • $195.00
    • Add to Cart
    • Printed Edition
    • Ships in 1-2 business days
    • $195.00
    • Add to Cart
    • Printed Edition + PDF
    • Immediate download
    • $263.00
    • Add to Cart

Customers Who Bought This Also Bought

 

About This Item

 

Full Description

This Standard is intended to define a standardized approach for auditing to determine the level of compliance of over-the-counter (OTC) drug products to 21 CFR Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General and 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals, well as incorporating additional retailer requirements. It refers to the requirements for good manufacturing practices (GMPs) applicable to all OTC drugs. It will assist in the determination of adequate facilities and controls for OTC drug manufacture with sufficient quality to ensure suitability for intended use.
 

Product Details

Published:
11/01/2020
ANSI:
ANSI Approved
Number of Pages:
44
File Size:
1 file , 1 MB
Note:
This product is unavailable in Ukraine, Belarus, Russia
 

Document History

  1. NSF/ANSI 455-4-2022


    Good Manufacturing Practices for Over-the-Counter Drugs

    • Most Recent

  2. NSF/ANSI 455-4-2021


    Good Manufacturing Practices for Over-the-Counter Drugs

    • Historical Version

  3. NSF/ANSI 455-4-2020

    👀 currently
    viewing


    Good Manufacturing Practices for Over-the-Counter Drugs

    • Historical Version

  4. NSF/ANSI 455-4-2018


    Good Manufacturing Practices for Over-the-Counter Drugs

    • Historical Version